Document Detail


Bupropion for amphetamine withdrawal syndrome.
MedLine Citation:
PMID:  11999825     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study was a case report of an amphetamine abuser who came to see doctor because of amphetamine withdrawal syndrome three days after stopping prolonged use of amphetamine. The patient was treated him with a slow-release bupropion at the dose of 150 mg per day. After taking bupropion, his withdrawal symptoms i.e. dysphoric mood, fatigue, somnolence, and psychomotor retardation gradually disappeared within two to three days. Moreover, his craving for amphetamines was absent. The authors discussed the possible application for the clinical use for amphetamine abusers or dependence.
Authors:
T Chan-Ob; N Kuntawongse; V Boonyanaruthee
Related Documents :
6818595 - Feeding stimulated by very low doses of d-amphetamine administered systemically or by m...
6440155 - The effects of thyrotropin releasing hormone on a visual discrimination task in rats.
24114865 - Soluble concentrations of the interleukin receptor family member st2 and beta blocker t...
6775335 - Continuous-access phencyclidine self-administration by rhesus monkeys leading to physic...
23636065 - Modulating autophagy improves cardiac function in a rat model of early-stage dilated ca...
6818595 - Feeding stimulated by very low doses of d-amphetamine administered systemically or by m...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of the Medical Association of Thailand = Chotmaihet thangphaet     Volume:  84     ISSN:  0125-2208     ISO Abbreviation:  J Med Assoc Thai     Publication Date:  2001 Dec 
Date Detail:
Created Date:  2002-05-09     Completed Date:  2002-06-10     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7507216     Medline TA:  J Med Assoc Thai     Country:  Thailand    
Other Details:
Languages:  eng     Pagination:  1763-5     Citation Subset:  IM    
Affiliation:
Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Thailand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Amphetamine / adverse effects*
Antidepressive Agents, Second-Generation / therapeutic use*
Bupropion / therapeutic use*
Humans
Male
Substance Withdrawal Syndrome / drug therapy*
Chemical
Reg. No./Substance:
0/Antidepressive Agents, Second-Generation; 300-62-9/Amphetamine; 34841-39-9/Bupropion

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of...
Next Document:  A family at risk of congenital adrenal hyperplasia: a molecular approach for prenatal diagnosis.